New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
10:45 EDTPEIX, WTW, TWTR, MACK, EXPEOptions with decreasing implied volatility: MACK WTW EXPE TWTR PEIX
News For MACK;WTW;EXPE;TWTR;PEIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 26, 2015
16:19 EDTTWTRTwitter VP of Corporate Development and Strategy to leave company
In a tweet, Rishi Carg, Twitter's VP of Corporate Development and Strategy, announced he is leaving the firm. Reference Link
16:00 EDTTWTROptions Update; June 26, 2015
Subscribe for More Information
07:14 EDTWTWWeight Watchers price target lowered to $4 from $5 at Credit Suisse
Subscribe for More Information
June 25, 2015
09:34 EDTTWTRActive equity options trading on open
Active equity options trading on open: AAPL FB NFLX AMZN BAC CVX TWTR INTC GILD BBBY
07:12 EDTEXPEExpedia Q2 trends positive, says Cantor
After conducting checks, Cantor says that hotel rates in Europe and the U.S. are improving, while Internet metrics look favorable for Expedia. The firm keeps a $120 price target and Buy rating on the stock.
07:06 EDTMACKMerrimack's MM-398 NDA granted priority review by FDA
Merrimack (MACK) and Baxalta Incorporated, a wholly-owned subsidiary of Baxter (BAX) announced that the New Drug Application for MM-398 has been accepted for review by the FDA. Merrimack is seeking U.S. marketing approval of MM-398 for the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy. In addition, the FDA has classified the NDA as having Priority Review status. The FDA has set a goal of October 24 to take action under the Prescription Drug User Fee Act. The European Medicines Agency has also accepted for review a Marketing Authorization Application for MM-398 for the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy. The acceptance of the MAA marks the beginning of the review process in the European Union for MM-398 in this indication.
June 24, 2015
16:00 EDTTWTRActionable Options for Wednesday, June, 24
iPath S&P 500 VIX Short-Term Futures up 30c to 17.32 Option volume leaders: AAPL FB NFLX BAC VALE MU BABA WMB T F EBAY FCX TWTR BBRY
14:13 EDTTWTRApple blocks use of app data to target ads, The Information reports
Apple (AAPL) is "quietly moving" to block companies from accessing data from other, unrelated apps, a practice which was used to target ads, says The Information. The report notes that Facebook (FB) and Twitter (TWTR) often analyze information from other apps on a user's phone in order to better target ads. Reference Link
10:26 EDTTWTRStocks with call strike movement; TWTR JCP
Twitter (TWTR) December 40 call option implied volatility increased 1% to 44, J.C. Penney (JCP) November 20 call option implied volatility decreased 5% to 42 according to IVolatility.
June 23, 2015
16:00 EDTTWTROptions Update; June 23, 2015
iPath S&P 500 VIX Short-Term Futures down 46c to 17. Option volume leaders: AAPL FB AAPL T BAC MU BTU WMB AMZN TWTR BBRY
09:36 EDTTWTRActive equity options trading on open
Subscribe for More Information
June 22, 2015
16:00 EDTTWTROptions Update; June 22, 2015
iPath S&P 500 VIX Short-Term Futures down 78c to 17.45. Option volume leaders: AAPL FB BAC CHK WMB BABA TWTR MU AMBA TSLA JPM
11:21 EDTTWTRStocks with call strike movement; TWTR BBRY
Subscribe for More Information
10:46 EDTEXPEAirbnb to hurt Priceline more than Expedia, Deutsche Bank says
Subscribe for More Information
10:00 EDTEXPEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:16 EDTTWTRTwitter retains Spencer Stuart to assist in CEO search process, CNBC says
According to a tweet from CNBC, Twitter has retained Spencer Stuart to assist in the CEO search process. Twitter will reportedly only consider "full-time" candidates. Reference Link
07:19 EDTEXPEExpedia upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Expedia (EXPE) to Buy citing an improving core business and cost synergies from acquisitions. The firm sees a path for Expedia to reach $200 per share over the next five year. It raised its price target for the stock to $130 from $95. Deutsche coupled the upgrade with a downgrade of Priceline (PCLN).
07:17 EDTEXPEPriceline downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
07:03 EDTWTWWeight Watchers to prepay portion of initial Tranche B-1 term loans
Weight Watchers commenced an offer to prepay at a discount to par up to $229M of Initial Tranche B-1 Term Loans outstanding under, and as defined in, and pursuant to the terms of, the Credit Agreement among the company, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent and an issuing bank, The Bank of Nova Scotia, as revolving agent, swingline lender and an issuing bank, and the other parties thereto. On June 22, 2015, the company accepted offers with a discount equal to or greater than 9.00% in respect of the Initial Tranche B-1 Term Loans. To complete the prepayment of the accepted offers, on June 26, 2015, the company will expend an aggregate amount of cash proceeds totaling approximately $77.2M plus an amount sufficient to pay accrued and unpaid interest on the amount to be prepaid to prepay approximately $84.9M of the Initial Tranche B-1 Term Loans, resulting in approximately $7.6 million in savings on the payment.
06:42 EDTEXPEExpedia upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use